Prescription drug · NDA
Juvmo (Tavapadon) NDC 0074-6105
Tavapadon 5 mg/1 · Tablet · Oral · AbbVie Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0074-6105-30 | 0007461053000074610530 | 30 TABLET in 1 BOTTLE (0074-6105-30)Marketed from Sep 25, 2026 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Juvmo
- Generic name (nonproprietary)
- tavapadon
- Active ingredients
- Tavapadon — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- AbbVie Inc.NDC labeler code 0074
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 220415
- Marketing start
- Listing expires
- Identifiers
- Product ID 0074-6105_b8de6e40-0be5-495c-8f8b-f171dbf39650SPL ID b8de6e40-0be5-495c-8f8b-f171dbf39650
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400074610530followed by a unit qualifier and the quantityPackage 00074-6105-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0074-6105
- What is NDC 0074-6105?
- 0074-6105 is the product NDC for Juvmo (tavapadon), Tavapadon 5 mg/1 tablet, listed with the FDA by AbbVie Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Juvmo (Tavapadon).
- What is the active ingredient?
- Tavapadon.
- Who is the labeler?
- AbbVie Inc., NDC labeler code 0074. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Juvmo?
- 4 other product NDCs are listed under this name. See all Juvmo NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Juvmo products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Juvmotavapadon | Tavapadon .25 mg/1 | TabletOral | AbbVie Inc. | 0074-5925 | 00074-5925-21 |
| Juvmotavapadon | — | Kit | AbbVie Inc. | 0074-6090 | 00074-6090-40 |
| Juvmotavapadon | Tavapadon 10 mg/1 | TabletOral | AbbVie Inc. | 0074-6210 | 00074-6210-30 |
| Juvmotavapadon | Tavapadon 15 mg/1 | TabletOral | AbbVie Inc. | 0074-6315 | 00074-6315-30 |
Other NDCs under NDA 220415
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Juvmotavapadon | Tavapadon .25 mg/1 | TabletOral | AbbVie Inc. | 0074-5925 |
| Juvmotavapadon | — | Kit | AbbVie Inc. | 0074-6090 |
| Juvmotavapadon | Tavapadon 10 mg/1 | TabletOral | AbbVie Inc. | 0074-6210 |
| Juvmotavapadon | Tavapadon 15 mg/1 | TabletOral | AbbVie Inc. | 0074-6315 |